pharmaceutic
Massimo Florio: could a ‘European Medicines Infrastructure’ solve market failures in pharmaceutical R&D?
Interview with Massimo Florio (Professor of Public Economics, University of Milan, Italy) about a new European approach to pharmaceutical policy. In response to the Covid-19 crisis, the European Union has increased its commitment to the EU public health agenda. It has strengthened the mandate of both the European Medicines Agency (EMA) and the European Centre ...
EU Project : PATH-TOX
PATH-TOX: Drug discovery is a time consuming, expensive and risky process. Each drug to market must undergo safety/ toxicity testing in animals which yields thousands of tissue sections that currently must be assessed manually by a trained veterinary pathology. However, there is a looming crisis due to the lack pathologists. The PATH-TOX consortium is led ...
Antibiotics on farms: Europe starts to curb bad practices
Resistant infections kill an estimated 33 000 people in the European Union annually.
